Xueting Bai
Co-Founder, CTO

Ph.D Dr.Bai has been the Chief Technical Officer since its foundation in 2020. Her role on the team consists of R&D product development in pharmacology, especially for the product in preclinical and clinical research.

Bai received her Ph.D. from the Department of Gastroenterology and Hepatology at the University Medical Center Groningen (UMCG) in the Netherlands. She was project leader of Grant Jan Kornelis de Cock Stichting in the Netherlands in 2011 and was responsible for the project of novel anti-inflammatory compounds to treat hepatitis. As a pharmacologist, Bai has expertise in animal modeling, operation, and administration of rodent and primary cell isolation (hepatocytes, Kupffer cells, hepatic stellate cells, and portal myofibroblast). She is the author of 5 journals and the owner of several scholarships in China and the Netherlands. Also, she was awarded an excellent master’s graduate thesis of the Guangdong providence in China in 2011.